AGM/EGMJun 9, 2026, 04:22 PM
Gossamer Bio Announces Special Meeting for Shareholder Votes
AI Summary
Gossamer Bio, Inc. has filed a definitive proxy statement (DEF 14A) announcing a Special Meeting of Stockholders to be held virtually on July 14, 2026. The meeting will address several key proposals, including the approval of share issuances related to an exchange offer, an amendment to the company's incentive award plan, an increase in authorized shares, and a potential reverse stock split. The company recently completed the early settlement of its exchange offer for its 5.00% Convertible Senior Notes due 2027, issuing new convertible notes, common stock, and warrants. The Board of Directors recommends a vote in favor of all proposals.
Key Highlights
- Gossamer Bio to hold Special Meeting of Stockholders on July 14, 2026, virtually via live webcast.
- Proposals include approving share issuances under Nasdaq Listing Rule 5635(d), amending the 2019 Incentive Award Plan, increasing authorized shares, and a potential reverse stock split.
- Exchange Offer for $200M in 5.00% Convertible Senior Notes due 2027 completed early settlement for $181.05M.
- New Convertible Notes of up to $72M, New Shares, Prefunded Warrants, and Purchase Warrants issued in exchange.
- Existing Noteholders holding 90.526% of outstanding notes tendered in the early settlement.
- Board unanimously recommends voting FOR all proposals.
Price Impact
More from GOSS